NCT02535026View on ClinicalTrials.gov

An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants

CompletedOBSERVATIONAL
Enrollment

580

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Breast Cancer
Trial Locations (4)

11600

Montevideo

LIMA 11

Lima

Lima 13

Lima

Unknown

Lima

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02535026 - An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants | Biotech Hunter | Biotech Hunter